NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain; Histology and Cell Biology Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
J Control Release. 2017 May 28;254:55-64. doi: 10.1016/j.jconrel.2017.03.386. Epub 2017 Mar 24.
The present study aimed to evaluate the incorporation of the natural lipid lycopene into niosome formulations based on cationic lipid DOTMA and polysorbate 60 non-ionic surfactant to analyze the potential application of this novel formulation to deliver genetic material into the rat retina. Both niosomes with and without lycopene were prepared by the reverse phase evaporation method and physicochemically characterized in terms of size, zeta potential, polydispersity index and capacity to condense, release and protect the DNA against enzymatic digestion. In vitro experiments were performed in ARPE-19 cells after complexion of niosomes with pCMS-EGFP plasmid at appropriate cationic lipid/DNA ratios. At 18/1 mass ratio, nioplexes containing lycopene had nanometric size, positive zeta potential, low polydispersity and were able to condense, release and protect DNA. Percentage of transfected cell was around 35% without compromising cell viability. The internalization pathways studies revealed a preference to caveolae mediated endocytosis and macropinocytosis, which could circumvent lysosomal degradation. Both subretinal and intravitreal administrations to the rat retina showed that nioplexes were able to transfect efficiently the outer segments of the retina, which offer reasonable hope for the treatment of many inherited retinal diseases by a safe non-viral vector formulation after the less invasive intravitreal administration.
本研究旨在评估天然脂质番茄红素与阳离子脂质 DOTMA 和聚山梨醇酯 60 非离子表面活性剂的混合体,以分析这种新型制剂在将遗传物质递送到大鼠视网膜中的潜在应用。含有和不含有番茄红素的脂质体均通过反相蒸发法制备,并从粒径、zeta 电位、多分散指数和压缩、释放以及保护 DNA 免受酶消化的能力等方面进行理化特性分析。在将合适的阳离子脂质/DNA 比例与 pCMS-EGFP 质粒复合后,在 ARPE-19 细胞中进行体外实验。在 18/1 的质量比下,含有番茄红素的脂质体纳米粒具有纳米级粒径、正 zeta 电位、低多分散性,能够压缩、释放和保护 DNA。在不影响细胞活力的情况下,转染细胞的百分比约为 35%。内化途径研究表明,该制剂优先通过胞饮作用和巨胞饮作用内化,这可以避免溶酶体降解。通过视网膜下和玻璃体内给药到大鼠视网膜,发现脂质体纳米粒能够有效地转染视网膜外节,这为通过玻璃体内给药这种更具侵袭性的方式,使用安全的非病毒载体制剂治疗许多遗传性视网膜疾病提供了合理的希望。